Jacques Tankovic

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq et al. · The Lancet Infectious Diseases · 2017 · 577 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods

Jacques Tankovic, Pierre Legrand, G De Gatines et al. · Journal of Clinical Microbiology · 1994 · 201 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro

Jacques Tankovic, Bruno Périchon, J Duval et al. · Antimicrobial Agents and Chemotherapy · 1996 · 173 citations · Full text

Life Sciences, Genetics, Microbiology +17

Singleand Double Mutations in <i>gyrA</i> but Not in <i>gyrB</i> AreAssociated with Low- and High-Level Fluoroquinolone Resistance in <i>Helicobacterpylori</i>

Jacques Tankovic, Christine Lascols, Quentin Sculo et al. · Antimicrobial Agents and Chemotherapy · 2003 · 140 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro

Thomas D. Gootz, Richard P. Zaniewski, S L Haskell et al. · Antimicrobial Agents and Chemotherapy · 1996 · 137 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17